The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, ...

Cretostimogene Monotherapy Demonstrated Sustained, Durable Complete Responses in High-Risk Bacillus Calmette Guérin (BCG)-Unresponsive ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

We recently published a list of the 12 Best IPO Stocks to Buy in 2025. In this article, we are going to take a look at where ...

Oral presentation to highlight preclinical data further supporting combination of KO-2806 with TKIs in ccRCC –– Company expects to present data ...

Predictive Oncology shares are trading higher on Tuesday after the company announced it developed predictive models to target ...

Mural Oncology (NASDAQ:MURA – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $18 ...

Mural Oncology (NASDAQ:MURA – Get Free Report) was downgraded by stock analysts at Raymond James from a “strong-buy” rating ...

Mural Oncology said that it won't continue developing its ovarian cancer drug candidate Nemvaleukin to be used in conjunction with Merck's Keytruda after results showed no statistical improvement in ...

Oncology services at Blanchard Valley Health System recently received accreditation under the American College of Surgeons ...

Across the recent three months, 4 analysts have shared their insights on CG Oncology CGON -2.73% Get Free Report , expressing a variety of opinions spanning from bullish to bearish. Summarizing their ...

Kennesaw State University assistant professor Chinomso Nwozichi has been honored by the Oncology Nursing Foundation with its ...